The Netherlands removed AstraZeneca warehouse remnants from people with disabilities, disabilities or illnesses

by Anton Theunissen | 9 May 2024, 18:05

...or pay via paypal

cards

Reactions

Comments that are not related to the topic of discussion will be deleted. Always keep comments respectful and substantive.

10 Comments
  1. Hans

    Hi Anton, the unabashed scurrilousness is outrageous. We have to keep calling a spade a spade. The psychopaths who had this on their conscience and still
    always have not a single glance worthy of judging. And whether the judiciary will ultimately turn out to be independent? …. We'll wait and see

    Reply
  2. Cees Mul

    Outrageous, but maybe it's even worse than you think.

    The harmful effects of the AZ injections came to light relatively quickly. Soon after the 'clot shot' things went wrong. Or not if you were lucky. That 1 in 50,000 is therefore what the seller himself indicates. The marketing department, so to speak. So in reality, it will be worse. Ogically, there will be a multiple of that number of serious side effects. Most people don't just drop dead, but first get serious complaints from which most people will normally recover. There are also lawsuits about this in England.

    The mRNA jabs will show a much more insidious pattern of side effects. If someone dies or becomes ill months after an injection, the bandage is not so quickly made. Astra Zeneca's side effects were 'blindingly obvious', just to stay in the English realm for a moment. Is AA now being used to make the mRNAs look better?

    Reply
  3. Willem

    What also played a role at that time (February-March 21) was that people had no choice which vaccine they received. If you were on the roll for AstraZeneca, you got AstraZeneca or you had to wait until everyone was vaccinated, which could mean that it was not your turn until September.

    I saw it as a marketing ploy: give people the illusion of choice and they will take more.

    At that time, I was still working at the Thrombosis Service and, as a doctor, I received worried phone calls from patients (all of whom have an increased risk of thrombosis) asking if they should take the Astra vaccine. I then said that I thought it would be wise to wait his turn, not to take a vaccine: the corona season (read flu season) was almost over and therefore the chance of 'infection' was small anyway. And by September, it would be clear how reliable/dangerous an mRNA vaccine is for people who are prone to clotting.

    I was unable to convince ANY of these worried callers at the time that in dubio abstinae (when in doubt, don't do it) was the best choice for those people. That's how the fear was.

    For what it's worth: here is a publication (on which I am a co-author) from which you can conclude that the vaccines (mostly Pfizer) that were given to patients at the time (who had their blood values checked at the Thrombosis Service) were thrombogenic for humans, given that the coagulation value (INR) decreased on average (and the lower the value the greater the chance of clotting). At the same time, on average, more people had an INR that was too high after vaccination (compared to before vaccination), which increases the risk of bleeding.

    Nice stuff.

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899332/

    'Our' conclusion: flush out, but check. By that time I was already gone...

    Reply
    1. Ward van Koperen

      Unbelievable. And there's just research that states that Pfizer and Moderna injection didn't show increased thrombosis levels. I don't believe any of it. That whole Big Pharma is really a deep black pool of horrible.

      Reply
    2. Anton Theunissen

      Unbelievable. Can you explain to both Jip and Janneke how to increase and decrease INR at the same time? Could that work differently for each patient or would it have been different vaccines?

      Reply
    3. Cees Mul

      Interesting contribution, Willem. Given the quotation marks and your comments, the recommendation was not entirely unanimous....This report -as far as I understand it- should set off quite a few alarm bells. And this is only about coagulation risks. Perhaps an idea to send the link to the science editors of NRC? They should wake up too, shouldn't they?
      I agree with Anton. A short explanation would be nice.

      Reply
      1. Willem

        Diffuse intravascular clotting sounds plausible to me.

        What is diffuse intravascular coagulation?

        Diffuse intravascular clotting – often abbreviated to 'DID' – is a serious condition in which blood clots form in small to medium-sized blood vessels. These blood clots are called microthrombi. They can get stuck in all kinds of organs. Because parts of those organs no longer receive oxygen-rich blood, they can die. This can cause extensive damage to all kinds of different organs. A situation in which multiple organs no longer work properly is called 'multi-organ failure'.

        Diffuse intravascular clotting can lead to many different complaints. Often the condition will lead to bleeding. Because clots form in the blood vessels on a large scale, many clotting factors are used up. This leads to a situation in which the body is no longer able to stop bleeding. This creates a clotting disorder. This is called 'consumption coagulopathy'. That is why people with DID often have a bleeding tendency.

        Reply
  4. Harry

    Hi Anton, very interesting, thanks!
    What is the source of that photo with "PGB group is still being pricked astra zenica"? Was that in an email?

    Reply
    1. Anton Theunissen

      Geen dank! Ja dat zijn e-mails uit de WOB-documenten. Onderaan het artikel staan hyperlinks naar die documenten, dat heb ik nu duidelijker gemaakt. Ook onder het plaatje zelf nu.

      Reply
  5. Armin

    This reminds me of the "injection" of the BA.1 bivalent vaccines in autumn 2022.

    For those who miss the context: at the end of 2021, the Omicron twins BA.1 and BA.2 arrived. What many people don't know is that these are genetically extremely different from each other, and just as different from each of them compared to Delta. Because BA.2 was initially missed, a bivalent vaccine based on BA.1 and Wuham was made. But by the fall of 2022, BA.1 was already completely extinct, and so was Wuham's Delta descendant. Either the variants that were circulating were all BA.2 or close BA.2 relatives (BA.4/5 differs only a handful or fewer mutations), for which the 'new' vaccine was no longer targeted.

    'Fortunately' there was already a switch and also a bi-valent for BA.4/5 for sale. However, the Netherlands had already bought a million pieces of the BA.1/Wuham shot and was going to prick it up before you got the new BA.4/5.

    The GGD website even openly stated "you are not allowed to choose".

    Reply

Post a Comment

Je e-mailadres wordt niet gepubliceerd. Required fields are marked with *